The amorphous solid dispersion of the poorly soluble ABT-102 forms nano/microparticulate structures in aqueous medium: impact on solubility
Open Access
- 1 November 2012
- journal article
- Published by Taylor & Francis Ltd in International Journal of Nanomedicine
- Vol. 7, 5757-5768
- https://doi.org/10.2147/IJN.S36571
Abstract
Amorphous solid dispersions (ASDs) are a promising formulation approach for poorly soluble active pharmaceutical ingredients (APIs), because they ideally enhance both dissolution rate and solubility. However, the mechanism behind this is not understood in detail. In the present study, we investigated the supramolecular and the nano/microparticulate structures that emerge spontaneously upon dispersion of an ASD in aqueous medium and elucidated their influence on solubility. The ASD, prepared by hot melt extrusion, contained the poorly soluble ABT-102 (solubility in buffer, 0.05 µg/mL), a hydrophilic polymer, and three surfactants. The apparent solubility of ABT-102 from the ASD-formulation was enhanced up to 200 times in comparison to crystalline ABT-102. At the same time, the molecular solubility, as assessed by inverse equilibrium dialysis, was enhanced two times. Asymmetrical flow field-flow fractionation in combination with a multiangle light-scattering detector, an ultraviolet detector, and a refractometer enabled us to separate and identify the various supramolecular assemblies that were present in the aqueous dispersions of the API-free ASD (placebo) and of binary/ternary blends of the ingredients. Thus, the supramolecular assemblies with a molar mass between 20,000 and 90,000 could be assigned to the polyvinylpyrrolidone/vinyl acetate 64, while two other kinds of assemblies were assigned to different surfactant assemblies (micelles). The amount of ABT-102 remaining associated with each of the assemblies upon fractionation was quantified offline with high-performance liquid chromatography–ultraviolet-visible. The polymeric and the micellar fraction contributed to the substantial increase in apparent solubility of ABT-102. Furthermore, a microparticulate fraction was isolated by centrifugation and analyzed by scanning electron microscopy, X-ray scattering, and infrared spectroscopy. The microparticles were found to be amorphous and to contain two of the surfactants besides ABT-102 as the main component. The amorphous microparticles are assumed to be the origin of the observed increase in molecular solubility ("true" supersaturation).Keywords
This publication has 29 references indexed in Scilit:
- Oral formulation strategies to improve solubility of poorly water-soluble drugsExpert Opinion on Drug Delivery, 2011
- In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionationJournal of Pharmaceutical and Biomedical Analysis, 2010
- Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utilityJournal of Drug Targeting, 2010
- Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous mediaEuropean Journal of Pharmaceutical Sciences, 2010
- Understanding the Behavior of Amorphous Pharmaceutical Systems during DissolutionPharmaceutical Research, 2010
- Review: physical chemistry of solid dispersionsJournal of Pharmacy and Pharmacology, 2009
- Analgesic potential of TRPV1 antagonistsBiochemical Pharmacology, 2009
- Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?Journal of Pharmaceutical Sciences, 2009
- The mechanisms of drug release from solid dispersions in water-soluble polymersInternational Journal of Pharmaceutics, 2001
- Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymersInternational Journal of Pharmaceutics, 2001